XML 19 R13.htm IDEA: XBRL DOCUMENT
v3.25.1

Commercial Mortgage Loans, Subordinate Loans and Other Lending Assets, Net | 3 Months Ended
--- | ---
Mar. 31, 2025
Receivables [Abstract] |
Commercial Mortgage Loans, Subordinate Loans and Other Lending Assets, Net | Note 4 – Commercial Mortgage Loans, Subordinate Loans and Other Lending Assets, Net Our loan portfolio was comprised of the following at March 31, 2025 and December 31, 2024 ($ in thousands):
Loan Type |  | March 31, 2025 |  |  | December 31, 2024 |
Commercial mortgage loans, net(1) |  | $ | 7,285,022 |  |  | $ | 6,715,347 |
Subordinate loans, net |  |  | 402,064 |  |  |  | 388,809 |
Total loans, net |  | $ | 7,687,086 |  |  | $ | 7,104,156 |
Note receivable, held for sale |  |  | 41,200 |  |  |  | 41,200 |
Carrying value, net |  | $ | 7,728,286 |  |  | $ | 7,145,356 |
(1) Includes $4.2 million and $8.3 million in 2025 and 2024, respectively, of contiguous financing structured as subordinate loans. Our loan portfolio consisted of 95% floating rate loans, based on amortized cost, net of Specific CECL Allowance, as of March 31, 2025 and December 31, 2024. Activity relating to our loan portfolio for the three months ended March 31, 2025 was as follows ($ in thousands):
|  | Principal Balance |  |  | Deferred Fees/Other Items |  |  | Specific CECL Allowance |  |  | Carrying Value, Net(1) |
December 31, 2024 |  | $ | 7,550,410 |  |  | $ | (31,718 | ) |  | $ | (342,500 | ) |  | $ | 7,176,192 |
New loan fundings |  |  | 460,452 |  |  |  | — |  |  |  | — |  |  |  | 460,452 |
Add-on loan fundings(2) |  |  | 72,867 |  |  |  | — |  |  |  | — |  |  |  | 72,867 |
Loan repayments and sale |  |  | (93,400 | ) |  |  | — |  |  |  | — |  |  |  | (93,400 | )
Gain (loss) on foreign currency translation |  |  | 148,405 |  |  |  | (503 | ) |  |  | — |  |  |  | 147,902 |
Deferred fees and other items(3) |  |  | — |  |  |  | (6,854 | ) |  |  | — |  |  |  | (6,854 | )
Amortization of fees |  |  | — |  |  |  | 5,839 |  |  |  | — |  |  |  | 5,839 |
March 31, 2025 |  | $ | 8,138,734 |  |  | $ | (33,236 | ) |  | $ | (342,500 | ) |  | $ | 7,762,998 |
General CECL Allowance(4) |  |  |  |  |  |  |  |  |  |  |  | (34,712 | )
Carrying value, net |  |  |  |  |  |  |  |  |  |  | $ | 7,728,286 |
(1) Includes Note receivable, held for sale. (2) Represents fundings subsequent to loan closing. (3) Other items primarily consist of purchase discounts or premiums, cost recovery interest, exit fees, and deferred origination expenses. (4) $6.1 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet. The following table details overall statistics for our loan portfolio at the dates indicated ($ in thousands):
|  | March 31, 2025(1) |  |  | December 31, 2024(1) |
Number of loans |  |  | 49 |  |  |  | 46 |
Principal balance |  | $ | 8,138,734 |  |  | $ | 7,550,410 |
Carrying value, net |  | $ | 7,728,286 |  |  | $ | 7,145,356 |
Unfunded loan commitments(2) |  | $ | 989,243 |  |  | $ | 840,627 |
Weighted-average cash coupon(3) |  |  | 7.3 | % |  |  | 7.5 | %
Weighted-average remaining fully-extended term(4) |  | 2.4 years |  |  | 2.5 years |
Weighted-average expected term(5) |  | 1.7 years |  |  | 1.9 years |
(1) Includes Note receivable, held for sale. (2) Unfunded loan commitments are primarily funded to finance construction costs, tenant improvements, leasing commissions, or carrying costs. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date. (3) For floating rate loans, based on applicable benchmark rates as of the specified dates. For loans placed on nonaccrual, the interest rate used in calculating weighted-average cash coupon is 0%. (4) Assumes all extension options are exercised. (5) Expected term represents our estimated timing of repayments as of the specified dates. Excludes risk-rated five loans. Property Type The table below details the property type of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):
|  | March 31, 2025 |  | December 31, 2024 |
Property Type |  | Carrying Value |  |  | % of Portfolio(1) |  | Carrying Value |  |  | % of Portfolio(1) |
Residential(2) |  | $ | 1,880,046 |  |  | 24.4% |  | $ | 1,556,819 |  |  | 21.8% |
Office |  |  | 1,818,410 |  |  | 23.5 |  |  | 1,756,965 |  |  |  | 24.6 |
Hotel |  |  | 1,602,392 |  |  | 20.8 |  |  | 1,575,270 |  |  | 22.1 |
Retail |  |  | 955,275 |  |  | 12.4 |  |  | 946,017 |  |  | 13.3 |
Industrial |  |  | 598,139 |  |  | 7.7 |  |  | 399,546 |  |  | 5.6 |
Mixed Use |  |  | 317,103 |  |  | 4.1 |  |  | 363,211 |  |  | 5.1 |
Other(3) |  |  | 550,433 |  |  | 7.1 |  |  | 537,164 |  |  | 7.5 |
Total |  | $ | 7,721,798 |  |  | 100.0% |  | $ | 7,134,992 |  |  | 100.0% |
General CECL Allowance(4) |  |  | (34,712 | ) |  |  |  |  | (30,836 | ) |  |  |
Total Carrying Value, net |  | $ | 7,687,086 |  |  |  |  | $ | 7,104,156 |  |  |  |
(1) Percentage of portfolio calculations are made prior to consideration of General CECL Allowance. (2) Includes residential-for-sale (6.4%), multifamily (5.5%), senior housing (6.0%), student housing (4.4%), and vacation rentals (2.1%) in 2025 and residential-for-sale (5.5%), multifamily (4.7%), senior housing (4.7%), student housing (4.6%), and vacation rentals (2.3%) in 2024. (3) Other property types include pu bs (2.8%), caravan parks (2.6%), and urban predevelopment (1.7%) in 2025, and pubs (2.9%), caravan parks (2.7%), and urban predevelopment (1.9%) in 2024. (4) $6.1 million and $5.9 million of the General CECL Allowance for 2025 and 2024, respectively, is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheets. Geography The table below details the geographic distribution of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):
|  | March 31, 2025 |  | December 31, 2024
Geographic Location |  | Carrying Value |  |  | % of Portfolio(1) |  | Carrying Value |  |  | % of Portfolio(1)
United Kingdom |  | $ | 2,489,538 |  |  | 32.1% |  | $ | 2,423,856 |  |  | 33.9%
New York City |  |  | 1,541,713 |  |  | 20.0 |  |  | 1,539,995 |  |  | 21.6
Other Europe(2) |  |  | 1,336,205 |  |  | 17.3 |  |  | 1,265,344 |  |  | 17.7
Southeast |  |  | 815,827 |  |  | 10.6 |  |  | 511,742 |  |  | 7.2
West |  |  | 632,901 |  |  | 8.2 |  |  | 489,008 |  |  | 6.9
Midwest |  |  | 560,052 |  |  | 7.3 |  |  | 560,436 |  |  | 7.9
Other(3) |  |  | 345,562 |  |  | 4.5 |  |  | 344,611 |  |  | 4.8
Total |  | $ | 7,721,798 |  |  | 100.0% |  | $ | 7,134,992 |  |  | 100.0%
General CECL Allowance(4) |  |  | (34,712 | ) |  |  |  |  | (30,836 | ) |  |
Total Carrying Value, net |  | $ | 7,687,086 |  |  |  |  | $ | 7,104,156 |  |  |
(1) Percentage of portfolio calculations are made prior to consideration of General CECL Allowance. (2) Other Europe includes Germa ny (8.2%), Italy (2.3%), Spain (3.4%), Sweden (3.2%) and the Netherlands (0.2%) i n 2025 and Germany (8.4%), Italy (2.4%), Spain (3.5%), Sweden (3.1%) and the Netherlands (0.3%) in 2024. (3) Other includes Northeast (0.5%), Mid-Atlantic (1.4%), Southwest (1.4%) and Other (1.2%) in 2025 and Northeast (0.6%), Mid-Atlantic (1.4%), Southwest (1.5%) and Other (1.3%) in 2024. (4) $6.1 million and $5.9 million of the General CECL Allowance for 2025 and 2024, respectively, is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheets. Risk Rating We assess the risk factors of each loan and assign a risk rating based on a variety of factors, including, without limitation, loan to value ("LTV") ratio, debt yield, property type, geographic and local market dynamics, physical condition, cash flow volatility, leasing and tenant profile, loan structure and exit plan, and project sponsorship. We apply these various factors on a case-by-case basis depending on the facts and circumstances for each loan, and the different factors may be given different weightings in different situations. This review is performed quarterly. Based on a 5-point scale, our loans are rated "1" through "5," from less risk to greater risk, which ratings are defined as follows: 1. Very low risk 2. Low risk 3. Moderate/average risk 4. High risk/potential for loss: a loan that has a risk of realizing a principal loss 5. Impaired/loss likely: a loan that has a high risk of realizing principal loss, has incurred principal loss, or an impairment has been recorded The following tables present the carrying value of our loan portfolio by year of origination and internal risk rating and gross write-offs by year of origination as of March 31, 2025 and December 31, 2024, respectively ($ in thousands):
March 31, 2025 |
|  |  |  |  |  |  |  |  |  |  | Amortized Cost(1) by Year Originated |
Risk Rating |  | Number of Loans |  |  | Total |  |  | % of Portfolio |  |  | 2025 |  |  | 2024 |  |  | 2023 |  |  | 2022 |  |  | 2021 |  |  | Prior |
1 |  |  | — |  |  | $ | — |  |  | — % |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
2 |  |  | 2 |  |  |  | 578,527 |  |  | 7.5% |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 578,527 |  |  |  | — |  |  |  | — |
3 |  |  | 41 |  |  |  | 6,729,675 |  |  | 87.2% |  |  |  | 447,501 |  |  |  | 1,251,720 |  |  |  | 667,922 |  |  |  | 1,570,998 |  |  |  | 1,220,525 |  |  |  | 1,571,009 |
4 |  |  | 2 |  |  |  | 288,961 |  |  | 3.7% |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 288,961 |
5 |  |  | 3 |  |  |  | 124,635 |  |  | 1.6% |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 124,635 |
Total |  |  | 48 |  |  | $ | 7,721,798 |  |  | 100.0% |  |  |  | 447,501 |  |  |  | 1,251,720 |  |  |  | 667,922 |  |  |  | 2,149,525 |  |  |  | 1,220,525 |  |  |  | 1,984,605 |
General CECL Allowance(2) |  |  |  | (34,712 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total loans, net |  |  | $ | 7,687,086 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-Average Risk Rating |  |  |  | 3.0 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross write-offs |  |  | $ | — |  |  |  |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
December 31, 2024 |
|  |  |  |  |  |  |  |  |  |  |  | Amortized Cost(1) by Year Originated |
Risk Rating |  | Number of Loans |  |  | Total |  |  | % of Portfolio |  |  |  | 2024 |  |  | 2023 |  |  | 2022 |  |  | 2021 |  |  | 2020 |  |  | Prior |
1 |  |  | — |  |  | $ | — |  |  |  | — | % |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
2 |  |  | 3 |  |  |  | 560,180 |  |  | 7.9% |  |  |  |  | — |  |  |  | — |  |  |  | 547,851 |  |  |  | 12,329 |  |  |  | — |  |  |  | — |
3 |  |  | 37 |  |  |  | 6,169,860 |  |  | 86.4% |  |  |  |  | 1,218,189 |  |  |  | 649,599 |  |  |  | 1,549,750 |  |  |  | 1,173,982 |  |  |  | 397,972 |  |  |  | 1,180,368 |
4 |  |  | 2 |  |  |  | 279,732 |  |  | 3.9% |  |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 279,732 |
5 |  |  | 3 |  |  |  | 125,220 |  |  | 1.8% |  |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 27,881 |  |  |  | 97,339 |
Total |  |  | 45 |  |  | $ | 7,134,992 |  |  | 100.0% |  |  |  | $ | 1,218,189 |  |  | $ | 649,599 |  |  | $ | 2,097,601 |  |  | $ | 1,186,311 |  |  | $ | 425,853 |  |  | $ | 1,557,439 |
General CECL Allowance(2) |  |  |  | (30,836 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total loans, net |  |  | $ | 7,104,156 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-Average Risk Rating |  |  |  | 3.0 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross write-offs |  |  | $ | 127,512 |  |  |  |  |  |  | $ | — |  |  | $ | — |  |  | $ | 127,512 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
(1) Net of Specific CECL Allowance. (2) $6.1 million and $5.9 million of the General CECL Allowance for 2025 and 2024, respectively, is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheets. CECL In accordance with ASC Topic 326 "Financial Instruments – Credit Losses" ("ASC 326"), which we refer to as the "CECL Standard," we record allowances for loans and held-to-maturity debt securities that are deducted from the carrying amount of the assets to present the net carrying value of the amounts expected to be collected on the assets. We record loan specific allowances as a practical expedient under the CECL Standard ("Specific CECL Allowance"), which we apply to assets that are collateral dependent and where the borrower or sponsor is experiencing financial difficulty. For the remainder of the portfolio, we record a general allowance ("General CECL Allowance," and together with the Specific CECL Allowance, "CECL Allowances") on a collective basis by assets with similar risk characteristics. We have elected to use the weighted-average remaining maturity ("WARM") method in determining a General CECL Allowance for a majority of our portfolio. In the future, we may use other acceptable methods, such as a probability-of-default/loss-given-default method. The following table summarizes changes in CECL Allowances for the three months ended March 31, 2025 ($ in thousands):
|  | Specific CECL |  |  | General CECL Allowance |  |  | Total CECL |  |  | CECL Allowance as % of Amortized Cost |
|  | Allowance(1) |  |  | Funded |  |  | Unfunded |  |  | Total |  |  | Allowance |  |  | General(1) |  |  | Total |
December 31, 2024 |  | $ | 342,500 |  |  | $ | 30,836 |  |  | $ | 5,948 |  |  | $ | 36,784 |  |  | $ | 379,284 |  |  |  | 0.52 | % |  |  | 5.07 | %
Changes: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Allowances (Reversals), net(2) |  |  | — |  |  |  | 3,876 |  |  |  | 132 |  |  |  | 4,008 |  |  |  | 4,008 |  |  |  |  |  |  |
Write-offs |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  |  |  |  |
March 31, 2025 |  | $ | 342,500 |  |  | $ | 34,712 |  |  | $ | 6,080 |  |  | $ | 40,792 |  |  | $ | 383,292 |  |  |  | 0.54 | % |  |  | 4.75 | %
(1) Loans evaluated for Specific CECL Allowance are excluded from General CECL Allowance pool. (2) During the three months ended March 31, 2025, our General CECL Allowance increased by $4.0 million. The increase was primarily due to a more adverse macroeconomic outlook as well as the effect of loan originations. The increase was partially offset by the favorable impacts of portfolio seasoning. The following table summarizes changes in CECL Allowances for the three months ended March 31, 2024 ($ in thousands):
|  | Specific CECL |  |  | General CECL Allowance |  |  | Total CECL |  |  | CECL Allowance as % of Amortized Cost |
|  | Allowance(1) |  |  | Funded |  |  | Unfunded |  |  | Total |  |  | Allowance |  |  | General(1) |  |  | Total |
December 31, 2023 |  | $ | 193,000 |  |  | $ | 26,482 |  |  | $ | 4,017 |  |  | $ | 30,499 |  |  | $ | 223,499 |  |  |  | 0.38 | % |  |  | 2.61 | %
Changes: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Allowances (Reversals), net(2) |  |  | 142,000 |  |  |  | 6,076 |  |  |  | (392 | ) |  |  | 5,684 |  |  |  | 147,684 |  |  |  |  |  |  |
March 31, 2024 |  | $ | 335,000 |  |  | $ | 32,558 |  |  | $ | 3,625 |  |  | $ | 36,183 |  |  | $ | 371,183 |  |  |  | 0.44 | % |  |  | 4.29 | %
(1) Loans evaluated for Specific CECL Allowance are excluded from General CECL Allowance pool. (2) During the three months ended March 31, 2024, our General CECL Allowance increased by $5.7 million. The increase was primarily related to extending our expected loan repayment dates as well as an increase to the historical loss rate derived from Trepp's data. The increase was partially offset by the favorable impacts of portfolio seasoning. During the three months ended March 31, 2024, we also recorded an additional $142.0 million Specific CECL Allowance on our Junior Mezzanine A Loan (as defined below - see "Manhattan Residential"), resulting in the loan’s aggregate Specific CECL allowance of $268.0 million. The additional allowance was recorded primarily due to a reduction in list pricing of remaining units and slower sales pace at the property. The slower sales velocity coincided with the continued overall softening in the midtown Manhattan ultra-luxury submarket. General CECL Allowance In determining the General CECL Allowance using the WARM method, an annual historical loss rate, adjusted for macroeconomic estimates, is applied to the amortized cost of an asset, or pool of assets, over each subsequent period for the assets' remaining expected life. We considered various factors including (i) historical loss experience in the commercial real estate lending market, (ii) timing of expected repayments and satisfactions, (iii) expected future funding, (iv) capital subordinate to us when we are the senior lender, (v) capital senior to us when we are the subordinate lender, and (vi) our current and future view of the macroeconomic environment for a reasonable and supportable forecast period. The CECL Standard requires the use of significant judgment to arrive at an estimated credit loss. There is significant uncertainty related to future macroeconomic conditions, including inflation, labor shortages and interest rates. We derive an annual historical loss rate based on a commercial mortgage-backed securities ("CMBS") database with historical losses from 1998 through the first quarter of 2025 provided by a third party, Trepp LLC ("Trepp"). We apply various filters to arrive at a CMBS dataset most analogous to our current portfolio from which to determine an appropriate historical loss rate. The annual historical loss rate is further adjusted to reflect our expectations of the macroeconomic environment for a reasonable and supportable forecast period of eight quarters. In assessing the macroeconomic environment, we consider macroeconomic factors, including unemployment rate, commercial real estate prices, and market liquidity. We compare the historical data for each metric to historical commercial real estate losses in order to determine the correlation of the data. We use projections, obtained from third-party service providers, of each factor to approximate the impact the macroeconomic outlook may have on our loss rate. The General CECL Allowance on subordinate loans is calculated by incorporating both the loan balance of the position(s) of the structurally senior third-party lender(s) and the balance of our subordinate loan(s). The subordinate loans, by virtue of being the first loss position, are required to absorb losses prior to the senior position(s) being impacted, resulting in a higher percentage allowance attributable to the subordinate loan. The General CECL Allowance on unfunded loan commitments is time-weighted based on our expected commitment to fund such obligations. The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheets within accounts payable, accrued expenses and other liabilities. The considerations in estimating our General CECL allowance for unfunded loan commitments are similar to those used for the related outstanding loans receivable. Additionally, we have made an accounting policy election to exclude accrued interest receivable from the amortized cost basis of the related commercial mortgage loans and subordinate loans and other lending assets in determining the General CECL Allowance, as any uncollectible accrued interest receivable is written off in a timely manner. As of March 31, 2025 and December 31, 2024, accrued interest receivable was $61.0 million and $58.5 million, respectively, and included within other assets on our condensed consolidated balance sheets. Although our secured debt obligations and senior secured term loan financing have a minimum tangible net worth maintenance covenant, the General CECL Allowance has no impact on these covenants as we are permitted to add back the General CECL Allowance for the computation of tangible net worth as defined in the respective agreements. The following table sets forth our General CECL Allowance as of March 31, 2025 and December 31, 2024 ($ in thousands):
|  | March 31, 2025 |  |  | December 31, 2024 |
Commercial mortgage loans, net |  | $ | 33,657 |  |  | $ | 30,167 |
Subordinate loans, net |  |  | 1,055 |  |  |  | 669 |
Unfunded commitments(1) |  |  | 6,080 |  |  |  | 5,948 |
Total General CECL Allowance |  | $ | 40,792 |  |  | $ | 36,784 |
(1) The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheets within accounts payable, accrued expenses and other liabilities. Specific CECL Allowance For collateral-dependent loans where we have deemed the borrower/sponsor to be experiencing financial difficulty and a more than moderate/average risk of realizing a principal loss, we have elected to apply a practical expedient in accordance with the CECL Standard in which the fair value of the underlying collateral is compared to the amortized cost of the loan in determining a Specific CECL Allowance. The Specific CECL Allowance is determined as the difference between the fair value of the underlying collateral and the carrying value of the loan (prior to the Specific CECL Allowance). When the repayment or satisfaction of a loan is dependent on a sale, rather than operations, of the collateral, the fair value is adjusted for the estimated cost to sell the collateral. Collateral-dependent loans evaluated for a Specific CECL Allowance are removed from the General CECL Allowance pool. The fair value of the underlying collateral is determined by using method(s) such as discounted cash flow, the market approach, or direct capitalization approach. The key unobservable inputs used to determine the fair value of the underlying collateral may vary depending on the information available to us and market conditions as of the valuation date. We regularly evaluate the extent and impact of any credit migration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan-by-loan basis. The Specific CECL Allowance is evaluated on a quarterly basis. Specifically, a property's operating results and any cash reserves are analyzed and used to assess (i) whether cash from operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and/or (iii) the liquidation value of the underlying collateral. We also evaluate the financial wherewithal of any loan guarantors as well as the borrower's competency in managing and operating the properties. In addition, we consider the overall economic environment, real estate sector and geographic sub-market in which the borrower operates. Such impairment analysis is completed and reviewed by asset management and finance personnel who utilize various data sources, including (i) periodic financial data such as debt service coverage ratio, property occupancy, tenant profile, rental rates, operating expenses, the borrower's exit plan, and capitalization and discount rates, (ii) site inspections and (iii) current credit spreads and discussions with market participants. The following table summarizes our risk rated 5 loans as of March 31, 2025, which were analyzed for Specific CECL Allowances ($ in thousands):
Type | Property type |  | Location |  | Amortized cost prior to Specific CECL Allowance |  |  | Specific CECL Allowance |  |  | Amortized cost |  |  | Interest recognition status/ as of date |  | Risk Rating
Mortgage | Retail(1)(2) |  | Cincinnati, OH |  | $ | 163,754 |  |  | $ | 67,000 |  |  | $ | 96,754 |  |  | Nonaccrual/ 10/1/2019 |  | 5
Mezzanine | Residential(3) |  | Manhattan, NY |  |  | 295,881 |  |  |  | 268,000 |  |  |  | 27,881 |  |  | Nonaccrual/ 7/1/2021 |  | 5
Mezzanine | Office(4) |  | Troy, MI |  |  | 7,500 |  |  |  | 7,500 |  |  |  | - |  |  | Nonaccrual/ 6/30/2024 |  | 5
Total |  |  |  | $ | 467,135 |  |  | $ | 342,500 |  |  | $ | 124,635 |  |  |  |  |
(1) The fair value of retail collateral was determined by applying a capitalization rate of 9.0%. (2) In September 2018, we entered a joint venture with Turner Consulting II, LLC ("Turner Consulting"), through an entity which owns the underlying property that secures our loan. Turner Consulting contributed 10% of the venture's equity and we contributed 90%. The entity was deemed to be a variable interest entity ("VIE"), and we determined that we are not the primary beneficiary of that VIE as we do not have the power to direct the entity's activ ities. During the second quarter of 2024, the loan's maturity was extended from September 2024 to September 2025. (3) The fair valu e of the residential collateral was determined by making certain projections and assumptions with respect to future performance and a discount rate of 10%. Any future change to the Specific CECL Allowance will be based upon a number of factors, including but not limited to the continued assessment of both the potential nominal value of remaining inventory as well as the expected sales velocity. (4) The fair value of the office collateral was determined by applying an exit capitalization rate of 10% and a discount rate of 20%. For the three months ended March 31, 2025, there was no change in our Specific CECL Allowance. Loan Modifications Pursuant to ASC 326 We provided the following modifications that require disclosure pursuant to ASC 326 during the twelve months ended March 31, 2025. Manhattan Residential — 111 West 57 th Street During the second quarter of 2024, our commercial mortgage loan secured by an ultra-luxury property in Manhattan, NY ("Senior Loan") was refinanced by a third-party lender, which resulted in a repayment of $108.3 million. The remaining Senior Loan balance was restructured into a subordinate loan ("Senior Mezzanine A Loan"), and the maturity date was extended by fourteen months to November 2025. Concurrently, the maturities of our additional mezzanine loans secured by the property ("Senior Mezzanine Loan" and "Junior Mezzanine A Loan") were also extended to November 2025. All three loans remain on nonaccrual status subsequent to the refinancing. Based on our analysis under ASC 310-20, we have deemed this refinance to be a continuation of our existing loans. Cleveland Multifamily In May 2021, we originated a first mortgage loan secured by a multifamily property in Cleveland, OH. During the second quarter of 2024, we modified our loan to convert from a floating rate of Secured Overnight Financing Rate ("SOFR") + 3.25% to a 6.0% fixed rate, and to provide a two year term extension. These modified terms are included in the determination of our general CECL allowance for the first quarter of 2025. The loan is performing pursuant to its modified contractual terms, and its risk rating remains a 3 as of March 31, 2025. Manhattan Office In March 2022, we originated a first mortgage loan secured by an office property in Manhattan, NY. During the second quarter of 2024, we modified our loan to convert from a floating rate of SOFR + 3.92% to a 5.0% fixed rate. The loan is performing pursuant to its modified contractual terms and its risk rating remains a 3 as of March 31, 2025. As of March 31, 2025 and December 31, 2024, the aggregate amortized cost basis, net of Specific CECL Allowance, of these modified receivables was $735.8 million and $721.7 million, respectively, or 9.5% and 10.1% of our aggregate commercial mortgage loans and subordinate loans by amortized cost, respectively. Unfunded commitments related to these loans as of March 31, 2025 and December 31, 2024 were $10.3 million and $10.6 million, respectively. Nonaccrual and Past Due Loans We cease accruing interest on loans if we deem the interest to be uncollectible with any previously accrued uncollected interest on the loan charged to interest income in the same period. The amortized cost basis, net of Specific CECL Allowance, for loans on nonaccrual was $499.9 million and $486.8 million as of March 31, 2025 and December 31, 2024, respectively. Under certain circumstances, we may apply the cost recovery method under which interest collected on a loan reduces the loan's amortized cost. We received $0.6 million in interest that reduced amortized cost under the cost recovery method during both the three months ended March 31, 2025 and the three months ended March 31, 2024. As of March 31, 2025 and December 31, 2024, the amortized cost basis, net of Specific CECL Allowance, for loans that are past due 90 days or more as to principal or interest, was $499.9 million and $486.8 million, respectively. As of March 31, 2025 and December 31, 2024, there were no loans with accrued interest between 30 and 89 days past due. Pre-payment penalties and accelerated fees We did no t recognize any pre-payment penalties and accelerated fees for the three months ended March 31, 2025. For the three months ended March 31, 2024, we recognized $0.1 million of pre-payment penalties and accelerated fees. Loan Sales From time to time, we may enter into sale transactions with other parties. All sale transactions are evaluated in accordance with ASC 860, "Transfers and Servicing" ("ASC 860"). In February 2025, we originated a $114.0 million commercial mortgage loan secured by a multifamily property located in Miami, FL, which included a $24.0 million contiguous subordinate loan. In March 2025, we sold our interest in the $24.0 million subordinate loan. We evaluated the transaction under ASC 860 and determined the sale met the criteria for sale accounting. We recorded no gain or loss related to this transaction. Held for Sale Loans are classified as held for sale if there is an intent to sell them in the short-term following the reporting date. Loans classified as held for sale are carried at the lower of amortized cost or fair value less costs to sell, unless the fair value option is elected at origination. Additionally, held for sale loans are not subject to the General CECL Allowance. As of March 31, 2025 and December 31, 2024, we held a $41.2 million promissory note classified as held for sale and recorded within Note receivable, held for sale on our consolidated balance sheet at its fair value. We received the promissory note during the fourth quarter of 2024 as consideration related to the sale of one of the eight hospitals that previously secured the Massachusetts Healthcare Loan as discussed in "Note 6 – Other Assets." Refer also to "Note 3 – Fair Value Disclosure" for further discussion on held for sale classification and fair value measurement policies. During the three months ended March 31, 2024, we entered into an agreement to sell a commercial mortgage loan collateralized by a hotel property located in Honolulu, HI at a price of 99.5%. We recorded a fair value adjustment of $0.7 million (representing the difference between the loan's amortized cost and the loan's fair value at the agreed upon price of 99.5%), which was included within valuation allowance, commercial mortgage loan held for sale on our condensed consolidated statement of operations for the three months ended March 31, 2024. The sale subsequently closed in April 2024.

X
- Definition The entire disclosure for investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate. Includes, but is not limited to, information for each mortgage loan receivable equaling or exceeding 3 percent of carrying amount of mortgage. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 29 -Publisher SEC Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 948 -SubTopic 310 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-29) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479628/948-310-S99-1 + Details
Name: | srt_MortgageLoansOnRealEstateByLoanDisclosureTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ReceivablesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration